Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
A clinical trial update from Stanford examining outcomes in pediatric and young adult B-cell lymphoid malignancies after commercially availa…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating CD19-directed CAR T-cells with dual co-stimulatory 4-1BB and CD3ζ domains in relapsed/refractory aggress…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies [Phase 1]
Phase 1 dose-escalation and expansion study of PRGN-3007 UltraCAR-T cells in patients with advanced hematologic and solid tumors has complet…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Pediatric Early Rehabilitation in Acute Lymphoblastic Leukemia [NA]
The clinical trial NCT06170385 on pediatric early rehabilitation for acute lymphoblastic leukemia has completed; the snippet does not provid…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL [Phase 1]
Phase 1 study evaluating CD19 CAR-T cells in B-cell non-Hodgkin lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia; th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: A Study to Determine Number of Patients Who Develop High Ammonia Levels After Receiving Recombinant Erwinia Asparaginase
This clinical trial update describes a study to determine how many patients develop elevated ammonia levels after receiving recombinant Erwi…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis [Phase 2]
Phase 2 clinical trial evaluating reduced-dose post-transplant cyclophosphamide as GVHD prophylaxis in HLA-mismatched unrelated donor periph…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: HIIT in Youth With Congenital Heart Disease (MedBIKE) [NA]
A clinical trial update for the MedBIKE study on high-intensity interval training in youth with congenital heart disease, currently recruiti…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating Tafasitamab (MOR00208) in pediatric patients with relapsed or refractory acute lymphoblastic leukem…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of CTD402 in T-ALL/LBL Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating CTD402 in patients with T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma is currently re…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Using Mobile Technology-assisted Outpatient Maintenance Therapy Pediatric ALL [NA]
A recruiting clinical trial in China is evaluating mobile technology-assisted outpatient maintenance therapy for pediatric acute lymphoblast…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL) [Phase 1, Phase 2]
This article outlines a Phase 1/2 clinical trial evaluating the safety and efficacy of asciminib in pediatric and young adult patients with …
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: TRacking Atopic Dermatitis Infants and Their Microbiome (TRAM)
A completed clinical trial (TRAM) that tracks the microbiome in infants with atopic dermatitis and pediatric acute lymphoblastic leukemia, s…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia [Phase 1]
A Phase 1 trial evaluating dalbavancin-based prophylaxis in children and adolescents with high-risk leukemia; the study is currently recruit…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy [Phase 1]
Phase 1 trial evaluating duvelisib after CAR-T therapy is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell
An observational study of people living with HIV treated with CD19-directed CAR T-cell therapy has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Reduce Sedentary Time in Acute Lymphoblastic Leukemia [NA]
A clinical trial evaluating reducing sedentary time in children with acute lymphoblastic leukemia has completed. The study was sponsored by …
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Phase I Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT [Phase 1]
A Phase I clinical trial for patients with advanced hematologic malignancies undergoing allogeneic hematopoietic cell transplantation is cur…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Expanded Access to Venetoclax
Expanded access to venetoclax is being offered for multiple hematologic cancers, including chronic lymphocytic leukemia, multiple myeloma, A…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies [Phase 1]
A Phase 1 trial evaluating flotetuzumab for relapsed or refractory CD123-positive hematologic malignancies has completed, providing initial …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy [Phase 3]
Phase 3 clinical trial evaluating a digital health intervention for self-management and telemonitoring in CAR-T therapy is currently recruit…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Clinical Study of Recombinant Anti-CD19m-CD3 Antibody Injection (A-319) [NA]
Clinical trial update for a recombinant anti-CD19m-CD3 antibody injection (A-319) for acute lymphoblastic leukemia, currently not yet recrui…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia [Phase 2]
Phase 2 clinical trial evaluating Total Marrow and Lymphoid Irradiation as a conditioning regimen before hematopoietic cell transplantation …
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating co-infusion of regulatory T cell–enriched donor lymphocytes with a CD3-depleted hematopoietic stem …
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Vaccine Immune Recovery After Leukemia
This clinical trial update reports results from a vaccine study aimed at immune recovery after pediatric acute lymphoblastic leukemia. The s…